zidovudine has been researched along with Mycoses in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (85.71) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chadha, N; Silakari, O | 1 |
Cotton, D; Dolin, R; Feinberg, J; Finkelstein, DM; Kahn, J; Molenberghs, G; Powderly, WG; Williams, PL | 1 |
Glick, ME | 1 |
Mascolini, M | 1 |
Garfunkel, AA; Glick, M | 1 |
Nightingale, SL | 1 |
2 review(s) available for zidovudine and Mycoses
Article | Year |
---|---|
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Bacterial Infections; Chemistry, Pharmaceutical; Cholinergic Antagonists; Drug Discovery; Humans; Indoles; Migraine Disorders; Mycoses; Neoplasms; Virus Diseases | 2017 |
HIV disease: therapy, related systemic and oral conditions--an update.
Topics: Acquired Immunodeficiency Syndrome; Bacterial Infections; Didanosine; HIV Infections; Humans; Mouth Diseases; Mycoses; Sarcoma, Kaposi; Virus Diseases; Zalcitabine; Zidovudine | 1992 |
1 trial(s) available for zidovudine and Mycoses
Article | Year |
---|---|
Patterns of opportunistic infections in patients with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cytomegalovirus Infections; Didanosine; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Male; Mycobacterium avium-intracellulare Infection; Mycoses; Pneumonia, Pneumocystis; Prospective Studies; Retrospective Studies; Risk Factors; Survival Rate; Zidovudine | 1996 |
4 other study(ies) available for zidovudine and Mycoses
Article | Year |
---|---|
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Combination; Fluconazole; HIV Infections; Humans; Mycoses; Pneumonia, Pneumocystis; Valacyclovir; Valine; Zidovudine | 1995 |
First women's HIV conference hears go-for-broke antiretroviral strategy.
Topics: Antifungal Agents; Antiviral Agents; CD4 Lymphocyte Count; Counseling; Female; Fluconazole; Health Education; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Mycoses; Pain; Practice Patterns, Physicians'; Pregnancy; Zidovudine | 1995 |
Mother-to-child HIV prevention: is elective C-section necessary?
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cesarean Section; Drug Administration Schedule; Elective Surgical Procedures; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mycoses; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 1999 |
From the Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Drug Labeling; Fluconazole; Humans; Mycoses; Patient Education as Topic; United States; United States Food and Drug Administration; Videotape Recording; Zidovudine | 1990 |